Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
Abstract
A multi-cancer early detection (MCED) test used to complement existing screening could increase the number of cancers detected through population screening, potentially improving clinical outcomes. The Circulating Cell-free Genome Atlas study (CCGA; NCT02889978) was a prospective, case-controlled, observational study and demonstrated that a blood-based MCED test utilizing cell-free DNA (cfDNA) sequencing in combination with machine learning...
Paper Details
Title
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set
Published Date
Sep 1, 2021
Journal
Volume
32
Issue
9
Pages
1167 - 1177
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History